Utility of fecal calprotectin as a discriminative biomarker between ulcerative colitis and irritable bowel syndrome and its ability to be used for the assessment of the remission stage of ulcerative colitis
Background and aim Fecal calprotectin (FC) has been proposed in recent studies as a sensitive, specific biomarker for the diagnosis of ulcerative colitis (UC). Hence, the present study sought to investigate the efficacy of FC for the diagnosis and monitoring of UC, as well as to assess the correlati...
Saved in:
Main Authors: | Hossam M Elsaadany (Author), Mohammed F Almaghraby (Author), Awatif A Edrees (Author), Yasser M Elsherbiny (Author), Roobina K Kumar (Author) |
---|---|
Format: | Book |
Published: |
SpringerOpen,
2016-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of the diagnostic performance of estimated fecal calprotectin and serum intelectin-1 and C-reactive protein solo or in combination for differentiation between patients with query ulcerative colitis and irritable bowel syndrome
by: Rizk Sayad R. Sarhan, et al.
Published: (2023) -
Systematic Review with Meta-Analysis: Fecal Calprotectin as a Surrogate Marker for Predicting Relapse in Adults with Ulcerative Colitis
by: Jiajia Li, et al.
Published: (2019) -
Long Pentraxin PTX 3 and Faecal Calprotectin as a Non Invasive Biomarkers for Ulcerative Colitis
by: Sherif Ezzat, et al.
Published: (2017) -
Patient preferences for active ulcerative colitis treatments and fecal microbiota transplantation
by: Deborah A. Marshall, et al.
Published: (2024) -
Patient perception of bowel urgency and remission in moderately to severely active Crohn's disease or ulcerative colitis: a qualitative study
by: Theresa Hunter Gibble, et al.
Published: (2024)